Good scientific decision: Adar Poonawalla on increase in gap between Covishield doses
New Delhi/IBNS: Adar Poonawalla, the CEO of Serum Institute of India (SII) that manufactures anti-Covid-19 vaccine Covishield, has welcomed the central government's decision to increase the gap between the first and second doses of the vaccine to 12-16 weeks.
SII, Bharat Biotech profiteering at expense of common man: Delhi Health Minister Jain
New Delhi/UNI: Delhi Health Minister Satyendar Jain on Thursday alleged that the pharmaceutical companies Serum Institute of India and Bharat Biotech are profiteering at the expense of the common man.
New Delhi/IBNS: Mounting pressure further on the Centre, several opposition leaders have criticised the Narendra Modi government over the difference in prices at which the Serum Institute of India (SII) has decided to sell its Covid-19 vaccine to the Centre, states and private hospitals.
'Believe Rs 3,000 cr govt aid will reach us soon, didn't wait but borrowed': SII CEO Adar Poonawalla
Mumbai/IBNS: Serum Institute of India (SII) has borrowed money from banks to ramp up the production of Covishield instead of waiting for the government's aid of Rs 3,000 crore to arrive.
Serum Institute seeks financial assistance from govt to boost capacity
New Delhi/IBNS: Adar Poonawalla, the CEO of world's largest vaccine manufacturer Serum Institute of India (SII), has told NDTV it needs Rs 3,000 crore in assistance from the Indian government to expand its production capacity which is currently "very stretched" in wake of the export restrictions imposed by the government last month.
India's COVID-19 vaccine diplomacy shines in South Asia and beyond
New Delhi: India's vaccine diplomacy seems to be shining as the country is giving millions of doses of COVID-19 vaccine to South Asian nations for the past few days, promising to help its neighbours, among others, at a time when the disease continues to grip the region. Now it is spreading beyond the regional boundaries as well.
Pune: 5 killed in fire at Serum Institute's under-construction facility
Pune/IBNS: At least five people have been killed in the fire which broke out at an under-construction facility of India's biotechnology and pharmaceuticals company Serum Institute of India (SII) here on Thursday.
Fire breaks out at Serum Institute's under-construction facility in Pune
Pune/IBNS: A fire broke out at an under-construction facility of India's biotechnology and pharmaceuticals company Serum Institute of India (SII) here on Thursday.
Pune/IBNS: The Serum Institute of India (SII), which has developed the Oxford vaccine to treat Novel Coronavirus in the country, said it would slap a defamation suit of Rs. 100 crore against an individual who claimed to have fallen ill after taking a dose of Covid-19 vaccine during the trial, media reports said.